Physician profile
Mark G Freeman
NPI 1780667865
$83,829.66
in general payments reported to CMS, 2019-2025
37 companies · $663 in 2025
The $663 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $6,684 · 2021: $3,162 · 2022: $15K · 2023: $8,892 · 2024: $635 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,325 · Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,325.00 |
| Food and Beverage | $1,865.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $65,495.71 | 2019-2025 | Real Intelligence, Trigen Intertan, Trigen Meta-Nail |
| Conformis, INC. | $9,775.07 | 2019-2023 | Itotal Hip Replacement System, Actera Hip Stem |
| Steris Corporation | $6,571.67 | 2020 | |
| Orthalign INC | $174.81 | 2019 | |
| Smoky Mountain Surgical LLC | $163.62 | 2023-2024 | |
| Depuy Synthes Sales INC. | $144.73 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $134.77 | 2019-2025 | Euflexxa |
| Linkbio Corp | $118.76 | 2024 | |
| Linvatec Corporation | $101.27 | 2022-2024 | Biobrace 23mm, Hall Power, Linvatec Shoulder Arthroscopy |
| Steris Instrument Management Services, INC. | $100.69 | 2020 | |
| Medacta USA, INC. | $100.28 | 2023-2024 | Gmk Sphere |
| Innovation Technologies INC | $88.46 | 2021 | |
| Paragon 28, INC. | $82.69 | 2022 | |
| Restor3d, INC. | $72.51 | 2023 | |
| Globus Medical, INC. | $70.60 | 2023 | Distal Femur Plate System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $66.39 | 2023-2024 | Iovera, Zilretta, Exparel |
| Medtronic, INC. | $58.10 | 2021-2025 | Osteocool Rf Ablation System, Plasmablade(Tm) |
| Organogenesis INC. | $53.05 | 2024 | Affinity |
| Zimmer Biomet Holdings, INC. | $43.60 | 2019-2024 | |
| Pacira Therapeutics, INC. | $40.35 | 2019-2021 | |
| Trice Medical, INC. | $35.15 | 2023 | |
| Medical Device Business Services, INC. | $32.17 | 2022 | |
| Heron Therapeutics, INC. | $27.63 | 2024 | Zynrelef |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $27.20 | 2024 | |
| Djo, LLC | $25.91 | 2025 | Cmf |
| Anika Therapeutics, INC. | $24.51 | 2025 | Integrity Implant |
| Acera Surgical, INC. | $24.25 | 2025 | Restrata Wound Matrix |
| Nalu Medical, INC. | $24.05 | 2023 | Nalu Neurostimulation System |
| Alpha Orthopedic Systems | $23.57 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $20.37 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $19.94 | 2019 | |
| Kci USA, INC. | $17.79 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.95 | 2023 | Andexxa |
| Ethicon US, LLC | $15.38 | 2023 | Ethicon |
| Abbvie INC. | $15.26 | 2023 | |
| Horizon Therapeutics Plc | $11.73 | 2019 | |
| Allergan, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.